U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

National Collaborating Centre for Women's and Children's Health (UK). Constipation in Children and Young People: Diagnosis and Management of Idiopathic Childhood Constipation in Primary and Secondary Care. London: RCOG Press; 2010. (NICE Clinical Guidelines, No. 99.)

  • Update information July 2017: The footnote in recommendation 4 was updated to link to the newest NICE guideline on coeliac disease. Footnotes in table 4 were corrected by NICE with manufacturer information that has changed since original publication.

Update information July 2017: The footnote in recommendation 4 was updated to link to the newest NICE guideline on coeliac disease. Footnotes in table 4 were corrected by NICE with manufacturer information that has changed since original publication.

Cover of Constipation in Children and Young People

Constipation in Children and Young People: Diagnosis and Management of Idiopathic Childhood Constipation in Primary and Secondary Care.

Show details

1Guidance summary

1.1. Key priorities for implementation

History-taking and physical examination

Establish during history-taking whether the child or young person has constipation. Two or more findings from table 1 indicate constipation.

Table 1. Key components of history-taking to diagnose constipation.

Table 1

Key components of history-taking to diagnose constipation.

If the child or young person has constipation, take a history using table 2 to establish a positive diagnosis of idiopathic constipation by excluding underlying causes. If a child or young person has any ‘red flag’ symptoms, do not treat them for constipation. Instead, refer them urgently to a healthcare professional with experience in the specific aspect of child health that is causing concern.

Table 2. Key components of history-taking to diagnose idiopathic constipation.

Table 2

Key components of history-taking to diagnose idiopathic constipation.

Do a physical examination. Use table 3 to establish a positive diagnosis of idiopathic constipation by excluding underlying causes. If a child or young person has any ‘red flag’ symptoms do not treat them for constipation. Instead, refer them urgently to a healthcare professional with experience in the specific aspect of child health that is causing concern.

Table 3. Key components of physical examination to diagnose idiopathic constipation.

Table 3

Key components of physical examination to diagnose idiopathic constipation.

Inform the child or young person and his or her parents or carers of a positive diagnosis of idiopathic constipation and also that underlying causes have been excluded by the history and/or physical examination. Reassure them that there is a suitable treatment for idiopathic constipation but that it may take several months for the condition to be resolved.

Digital rectal examination

Do not perform a digital rectal examination in children or young people older than 1 year with a ‘red flag’ (see tables 2 and 3) in the history-taking and/or physical examination that might indicate an underlying disorder. Instead, refer them urgently to a healthcare professional competent to perform a digital rectal examination and interpret features of anatomical abnormalities or Hirschsprung's disease.

Disimpaction

Assess all children and young people with idiopathic constipation for faecal impaction, including children and young people who were originally referred to the relevant services because of ‘red flags’ but in whom there were no significant findings following further investigations (see tables 2 and 3). Use a combination of history-taking and physical examination to diagnose faecal impaction – look for overflow soiling and/or faecal mass palpable abdominally and/or rectally if indicated.

Offer the following oral medication regimen for disimpaction if indicated:

  • Polyethylene glycol 3350 + electrolytes, using an escalating dose regimen (see table 4), as the first-line treatment. Polyethylene glycol 3350 + electrolytes may be mixed with a cold drink.*
  • Add a stimulant laxative (see table 4) if polyethylene glycol 3350 + electrolytes does not lead to disimpaction after 2 weeks.
  • Substitute a stimulant laxative singly or in combination with an osmotic laxative such as lactulose (see table 4) if polyethylene glycol 3350 + electrolytes is not tolerated.
  • Inform families that disimpaction treatment can initially increase symptoms of soiling and abdominal pain.
Table 4. Laxatives: recommended doses.

Table 4

Laxatives: recommended doses.

Maintenance therapy

Offer the following regimen for ongoing treatment or maintenance therapy:

  • Polyethylene glycol 3350 + electrolytes as the first line treatment.*
  • Adjust the dose of polyethylene glycol 3350 + electrolytes according to symptoms and response. As a guide for children and young people who have had disimpaction the starting maintenance dose might be half the disimpaction dose (see table 4).
  • Add a stimulant laxative (see table 4) if polyethylene glycol 3350 + electrolytes does not work.
  • Substitute a stimulant laxative if polyethylene glycol 3350 + electrolytes is not tolerated by the child or young person. Add another laxative such as lactulose or docusate (see table 4) if stools are hard.
  • Continue medication at maintenance dose for several weeks after regular bowel habit is established – this may take several months. Children who are toilet training should remain on laxatives until toilet training is well established. Do not stop medication abruptly: gradually reduce the dose over a period of months in response to stool consistency and frequency. Some children and young people may require laxative therapy for several years. A minority may require ongoing laxative therapy.

Diet and lifestyle

Do not use dietary interventions alone as first-line treatment for idiopathic constipation.

Treat constipation with laxatives and a combination of:

  • Negotiated and non-punitive behavioural interventions suited to the child or young person's stage of development. These could include scheduled toileting and support to establish a regular bowel habit, maintenance and discussion of a bowel diary, information on constipation, and use of encouragement and rewards systems.
  • Dietary modifications to ensure a balanced diet and sufficient fluids are consumed.

Information and support

Offer children and young people with idiopathic constipation and their families a point of contact with specialist healthcare professionals including school nurses who can give ongoing support.

1.2. Recommendations

Assessment and diagnosis

History-taking and physical examination

Establish during history-taking whether the child or young person has constipation. Two or more findings from table 1 indicate constipation.

If the child or young person has constipation take a history using table 2 to establish a positive diagnosis of idiopathic constipation by excluding underlying causes. If a child or young person has any ‘red flag’ symptoms do not treat for constipation. Instead, refer them urgently to a healthcare professional with experience in the specific aspect of child health that is causing concern.

Do a physical examination. Use table 3 to establish positive diagnosis of idiopathic constipation by excluding underlying causes. If a child or young person has any ‘red flag’ symptoms do not treat them for constipation. Instead refer them urgently to a healthcare professional with experience in the specific aspect of child health that is causing concern.

If the history-taking and/or physical examination show evidence of faltering growth treat for constipation and test for coeliac disease** and hypothyroidism.

If either the history-taking or the physical examination show evidence of possible maltreatment treat for constipation and refer to ‘When to suspect child maltreatment’, NICE clinical guideline 89 (2009).

If the physical examination shows evidence of perianal streptococcal infection, treat for constipation and also treat the infection.

Inform the child or young person and his or her parents or carers of a positive diagnosis of idiopathic constipation and also that underlying causes have been excluded by the history and/or physical examination. Reassure them that there is a suitable treatment for idiopathic constipation but that it may take several months for the condition to be resolved.

Digital rectal examination

A digital rectal examination should be undertaken only by healthcare professionals competent to interpret features of anatomical abnormalities or Hirschsprung's disease.

If a child younger than 1 year has a diagnosis of idiopathic constipation that does not respond to optimum treatment within 4 weeks, refer them urgently to a healthcare professional competent to perform a digital rectal examination and interpret features of anatomical abnormalities or Hirschsprung's disease.

Do not perform a digital rectal examination in children or young people older than 1 year with a ‘red flag’ (see tables 2 and 3) in the history-taking and/or physical examination that might indicate an underlying disorder. Instead, refer them urgently to a healthcare professional competent to perform a digital rectal examination and interpret features of anatomical abnormalities or Hirschsprung's disease.

For a digital rectal examination ensure:

  • privacy
  • informed consent is given by the child or young person, or the parent or legal guardian if the child is not able to give it, and is documented
  • a chaperone is present
  • the child or young person's individual preferences about degree of body exposure and gender of the examiner are taken into account
  • all findings are documented.

Clinical investigations

Endoscopy

Do not use gastrointestinal endoscopy to investigate idiopathic constipation.

Coeliac disease and hypothyroidism

Test for coeliac disease** and hypothyroidism in the ongoing management of intractable constipation in children and young people if requested by specialist services.

Manometry

Do not use anorectal manometry to exclude Hirschsprung's disease in children and young people with chronic constipation.

Radiography

Do not use a plain abdominal radiograph to make a diagnosis of idiopathic constipation

Consider using a plain abdominal radiograph only if requested by specialist services in the ongoing management of intractable idiopathic constipation.

Rectal biopsy

Do not perform rectal biopsy unless any of the following clinical features of Hirschsprung's disease are or have been present:

  • delayed passage of meconium (more than 48 hours after birth in term babies)
  • constipation since first few weeks of life
  • chronic abdominal distension plus vomiting
  • family history of Hirschsprung's disease
  • faltering growth in addition to any of the previous features.

Transit studies

Do not use transit studies to make a diagnosis of idiopathic constipation.

Consider using transit studies in the ongoing management of intractable idiopathic constipation only if requested by specialist services.

Ultrasound

Do not use abdominal ultrasound to make a diagnosis of idiopathic constipation.

Consider using abdominal ultrasound in the ongoing management of intractable idiopathic constipation only if requested by specialist services.

Clinical management

Disimpaction

Assess all children and young people with idiopathic constipation for faecal impaction, including children and young people who were originally referred to the relevant services because of ‘red flags’ but in whom there were no significant findings following further investigations (see tables 2 and 3). Use a combination of history-taking and physical examination to diagnose faecal impaction – looking for overflow soiling and/or faecal mass palpable abdominally and/or rectally if indicated.

Start maintenance therapy if the child or young person is not faecally impacted.

Offer the following oral medication regimen for disimpaction if indicated:

  • Polyethylene glycol 3350 + electrolytes, using an escalating dose regimen (see table 4) as the first-line treatment*. Polyethylene glycol 3350 + electrolytes may be mixed with a cold drink.
  • Add a stimulant laxative using table 4 if polyethylene glycol 3350 + electrolytes does not lead to disimpaction after 2 weeks.
  • Substitute a stimulant laxative singly or in combination with an osmotic laxative such as lactulose (see table 4) if polyethylene glycol 3350 + electrolytes is not tolerated.
  • Inform families that disimpaction treatment can initially increase symptoms of soiling and abdominal pain initially

Do not use rectal medications for disimpaction unless all oral medications have failed and only if the child or young person and their family consent.

Administer sodium citrate enemas only if all oral medications for disimpaction have failed.

Do not administer phosphate enemas for disimpaction unless under specialist supervision in hospital/healthcare centre/clinic, and only if all oral medications and sodium citrate enemas have failed.

Do not perform manual evacuation of the bowel under anaesthesia unless optimal treatment with oral and rectal medications has failed.

Review children and young people undergoing disimpaction within 1 week.

Maintenance therapy

Start maintenance therapy as soon as the child or young person's bowel is disimpacted.

Reassess children frequently during maintenance treatment to ensure they do not become reimpacted and assess issues in maintaining treatment such as taking medicine and toileting. Tailor the frequency of assessment to the individual needs of the child and their families (this could range from daily contact to contact every few weeks). Where possible, reassessment should be provided by the same person/team.

Offer the following regimen for ongoing treatment or maintenance therapy:

  • Polyethylene glycol 3350 + electrolytes as the first-line treatment.*
  • Adjust the dose of polyethylene glycol 3350 + electrolytes according to symptoms and response. As a guide for children and young people who have had disimpaction the starting maintenance dose might be half the disimpaction dose (see table 4).
  • Add a stimulant laxative (see table 4) if polyethylene glycol 3350 + electrolytes does not work.
  • Substitute a stimulant laxative if polyethylene glycol 3350 + electrolytes is not tolerated by the child or young person. Add another laxative such as lactulose or docusate (see table 4) if stools are hard.
  • Continue medication at maintenance dose for several weeks after regular bowel habit is established – this may take several months. Children who are toilet training should remain on laxatives until toilet training is well established. Do not stop medication abruptly: gradually reduce the dose over a period of months in response to stool consistency and frequency. Some children and young people may require laxative therapy for several years. A minority may require ongoing laxative therapy.

Diet and lifestyle

Do not use dietary interventions alone as first-line treatment for idiopathic constipation.

Treat constipation with laxatives and a combination of:

  • Negotiated and non-punitive behavioural interventions suited to the child or young person's stage of development. These could include scheduled toileting and support to establish a regular bowel habit, maintenance and discussion of a bowel diary, information on constipation, and use of encouragement and rewards systems
  • Dietary modifications to ensure a balanced diet and sufficient fluids are consumed (see recommendation below).

Advise parents and children (where appropriate) that a balanced diet should include:

  • Adequate fluid intake (see table 5)
  • Adequate fibre. Recommend including foods with a high fibre content (such as fruit, vegetables, high-fibre bread, baked beans and wholegrain breakfast cereals) (not applicable to exclusively breastfed infants). Do not recommend unprocessed bran, which can cause bloating and flatulence and reduce the absorption of micronutrients.
Table 5. American dietary recommendations: IoM (2005) IoM (Institute of Medicine) (2005).

Table 5

American dietary recommendations: IoM (2005) IoM (Institute of Medicine) (2005). Dietary reference intakes for water, potassium, sodium chloride and sulfate. Washington DC: The National Academies Press.

Provide children and young people with idiopathic constipation and their families with written information about diet and fluid intake.

In children and young people with idiopathic constipation, start a cows' milk exclusion diet only on the advice of the relevant specialist services.

Advise daily physical activity that is tailored to the child or young person's stage of development and individual ability as part of ongoing maintenance in children and young people with idiopathic constipation.

Psychological interventions

Do not use biofeedback for ongoing treatment in children and young people with idiopathic constipation.

Do not routinely refer children and young people with idiopathic constipation to a psychologist or child and adolescent mental health services unless the child or young person has been identified as likely to benefit from receiving a psychological intervention.

Antegrade colonic enema procedure

Refer children and young people with idiopathic constipation who still have unresolved symptoms on optimum management to a paediatric surgical centre to assess their suitability for an antegrade colonic enema (ACE) procedure.

Ensure that all children and young people who are referred for an ACE procedure have access to support, information and follow-up from paediatric healthcare professionals with experience in managing children and young people who have had an ACE procedure.

Information and support

Provide tailored follow-up to children and young people and their parents or carers according to the child or young person's response to treatment, measured by frequency, amount and consistency of stools (use the Bristol Stool Form Scale to assess this, see appendix G). This could include:

  • telephoning or face-to-face talks
  • giving detailed evidence-based information about their condition and its management, this might include, for example, the ‘Understanding NICE guidance’ leaflet for this guideline
  • giving verbal information supported by (but not replaced by) written or website information in several formats about how the bowels work, symptoms that might indicate a serious underlying problem, how to take their medication, what to expect when taking laxatives, how to poo, origins of constipation, criteria to recognise risk situations for relapse (such as worsening of any symptoms, soiling etc.) and the importance of continuing treatment until advised otherwise by the healthcare professional.

Offer children and young people with idiopathic constipation and their families a point of contact with specialist healthcare professionals, including school nurses, who can give ongoing support.

Healthcare professionals should liaise with school nurses to provide information and support, and to help school nurses raise awareness of the issues surrounding constipation with children and young people and school staff.

Refer children and young people with idiopathic constipation who do not respond to initial treatment within 3 months to a practitioner with expertise in the problem.

1.3. Key research recommendations

Disimpaction

What is the effectiveness of polyethylene glycol 3350 + electrolytes in treating idiopathic constipation in children younger than 1 year old, and what is the optimum dosage?

Why this is important?

There is some evidence that treatment of constipation is less effective if faecal impaction is not dealt with first. Disimpaction with oral macrogols is recommended for children and their use avoids the need for rectal treatments.

Rectal treatments are used more commonly in hospital than at home. Although relatively few infants are admitted to hospital, there would be savings if initially all children were disimpacted at home.

Polyethylene glycol 3350 + electrolytes, an oral macrogol, is licensed for disimpaction in children older than 5 years. Increasing experience has shown that it is effective in infants younger than 1 year old, but evidence is limited to small case series. If dosage guidelines and evidence on macrogol use in infants were obtained and published, more healthcare professionals might be encouraged to try macrogols in this age group. It would also allow the guideline to be applicable across the whole paediatric age group.

Information and support

Is age-specific information more effective than non-age-specific information in increasing children's knowledge and understanding of constipation and its treatment, and what information should be given?

Why this is important?

When treating idiopathic constipation it is helpful if children understand how the bowel works, what can go wrong and what they can do about it. Younger children (pre toilet training) need to allow stools to come out. Older children have a more active role and need to develop a habit of sitting on the toilet each day, pushing stools out and taking all prescribed medication. Volition from the child is vital to establish and sustain a regular toilet habit. Intended learning outcomes are similar for all age groups.

Theory-based research has led to the development of some materials such as ‘Sneaky-poo’ that are not appropriate for young children. To help clinicians and parents motivate children to fully participate in managing their constipation it is important to discover how best to communicate information to them, what materials are most effective and, specifically, what works at different ages.

Information and support

Do specialist nurse-led children's continence services or traditional secondary care services provide the most effective treatment for children with idiopathic constipation (with or without faecal incontinence) that does not respond fully to primary treatment regimens? This should consider clinical and cost effectiveness, and both short-term (16 weeks) and long-term (12 months) resolution.

Why this is important?

By the time children reach tertiary care they have often suffered years of constipation with or without faecal incontinence and have intractable constipation.

Findings from one trial1 have suggested that children referred to a tertiary gastroenterology service and diagnosed as having idiopathic constipation are managed as effectively by nurse-led follow-up as by a consultant paediatric gastroenterology service. Parent satisfaction was improved by the nurse-led service. However the nurse-led service may require increased resources because many more contacts are made. Several services with a similar model of care have been established but cost effectiveness has not been formally assessed.

For coherent services to develop across the UK, the cost effectiveness of specialist nurse-led services provided as first referral point if primary treatment regimens have not worked needs to be examined.

Antegrade colonic enema

What is the effectiveness of different volumes and types of solutions used for colonic washouts in children who have undergone an antegrade colonic enema (ACE) procedure for intractable chronic idiopathic constipation?

Why this is important?

The ACE procedure has a role in the management of people with treatment-resistant symptoms. Close follow-up is integral to the effectiveness of this technique to allow safe and effective administration of washout solutions.

The choice of washout solutions and frequency of administration differs between centres. Outcomes may be improved by evaluating how experienced centres choose washout solutions and by comparing techniques.

Centres offering the ACE procedure as treatment for children with chronic idiopathic constipation should be surveyed for their choice of washout solution. To determine the perceived strengths and weaknesses of each solution, the survey should cover enema, choice of washout fluid, volumes and frequency of administration.

Information and support

What is the impact of specific models of service on both clinical and social outcomes to deliver timely diagnosis and treatment interventions in children with chronic idiopathic constipation and their families?

Why this is important?

There has been no research to explore the social impact on children with constipation and their families, and many of the clinical studies have been of mediocre quality. A comprehensive study is needed that investigates the effectiveness of specific models of care, and that takes into consideration both the clinical and social impact of this complex condition.

1.4. Additional research recommendations

What is the diagnostic and prognostic value of the abdominal ultrasound in children with chronic idiopathic constipation?

What is the clinical effectiveness of increasing physical activity for ongoing treatment/ maintenance in children with chronic idiopathic constipation?

In infants with chronic idiopathic constipation, does changing from one infant milk formula to another improve symptoms? (For example, standard infant formula versus infant formula with oligosaccharides versus standard infant formula + laxative)

What is the effectiveness of complementary therapies (hypnotherapy) for ongoing treatment/maintenance in children with chronic idiopathic constipation?

What are the experiences of children who have undergone ACE procedure due to intractable chronic idiopathic constipation?

What is the effectiveness of polyethylene glycol 3350 + electrolytes as compared to stimulant laxatives (senna, bisacodyl and sodium picosulfate) in treating idiopathic constipation in children older than 2 years?

1.5. Care pathway

Flowchart Icon

Flowchart (PDF, 846K)

Footnotes

*

At the time of publication (May, 2010), Movicol Paediatric Plain is the only macrogol licensed for children under 12 years that includes electrolytes. It does not have UK marketing authorisation for use in faecal impaction in children under 5 years, or for chronic constipation in children under 2 years. Informed consent should be obtained and documented. Movicol Paediatric Plain is the only macrogol licensed for children under 12 years that is also unflavoured.

**

See also “Coeliac disease: recognition and assessment of coeliac disease” (NICE clinical guideline 86). Available from www​.nice.org.uk/guidance/CG86

Copyright © 2010, National Collaborating Centre for Women's and Children's Health.

No part of this publication may be reproduced, stored or transmitted in any form or by any means, without the prior written permission of the publisher or, in the case of reprographic reproduction, in accordance with the terms of licences issued by the Copyright Licensing Agency in the UK [www.cla.co.uk]. Enquiries concerning reproduction outside the terms stated here should be sent to the publisher at the UK address printed on this page.

The use of registered names, trademarks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant laws and regulations and therefore for general use.

Bookshelf ID: NBK65368